Compare UFPI & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UFPI | BLCO |
|---|---|---|
| Founded | 1955 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Forest Products | Ophthalmic Goods |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.7B |
| IPO Year | 1993 | 2022 |
| Metric | UFPI | BLCO |
|---|---|---|
| Price | $90.47 | $16.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 14 |
| Target Price | ★ $114.00 | $17.31 |
| AVG Volume (30 Days) | 449.9K | ★ 488.7K |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | ★ 1.55% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.39 | N/A |
| Revenue | ★ $6,452,521,000.00 | $4,976,000,000.00 |
| Revenue This Year | N/A | $8.08 |
| Revenue Next Year | $2.12 | $5.77 |
| P/E Ratio | $16.79 | ★ N/A |
| Revenue Growth | N/A | ★ 6.23 |
| 52 Week Low | $87.11 | $10.45 |
| 52 Week High | $135.00 | $20.71 |
| Indicator | UFPI | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 45.38 | 63.75 |
| Support Level | $91.04 | $16.73 |
| Resistance Level | $93.98 | $17.70 |
| Average True Range (ATR) | 2.01 | 0.53 |
| MACD | 0.21 | 0.16 |
| Stochastic Oscillator | 48.63 | 73.93 |
UFP Industries Inc is a supplier of lumber to the manufactured housing industry. Today UFP Industries is a multibillion-dollar holding company with subsidiaries around the globe that serve three markets: retail, packaging and construction. Its business segments consist of UFP Retail Solutions, UFP Packaging, UFP Construction, All other and Corporate.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.